Jennifer Carlson Aske (Aske Jennifer, Jennifer Aske, Jennifer C Aske)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 18

Top Venues

International journal of molecular sciences

Cancers

Biomedicines

Pharmaceuticals (Basel, Switzerland)

Avera McKennan Hospital and University Health Center

University of Minnesota (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Avera McKennan Hospital and University Health Center

United States

Lab Supervisor :: Precision Oncology

Sanford Research

United States

Senior Research Associate

Education History

University of Minnesota

United States

MSC

University of North Dakota

United States

BSC

Publications

Raed Sulaiman, Adam Dale, Xiaoqian Lin, Jennifer Carlson Aske, Kris Gaster, David Starks, Luis Rojas Espaillat, Pradip De, Nandini Dey
Atlas of Tumor and Tumor Microenvironment Cells of Lymphovascular Space Invasion (LVSI) in High-Grade Serous Endometrial Adenocarcinoma: A Case Study. International journal of molecular sciences 25 (6) (2024)
Raed Sulaiman, Adam Dale, Xiaoqian Lin, Jennifer Carlson Aske, Kris Gaster, David Starks, Luis Rojas Espaillat, Pradip De, Nandini Dey
Atlas of Tumor and Tumor Microenvironment Cells of Lymphovascular Space Invasion (LVSI) in High-Grade Serous Endometrial Adenocarcinoma: A Case Study. International journal of molecular sciences 25 (6) (2024)
Raed Sulaiman, Adam Dale, Xiaoqian Lin, Jennifer Carlson Aske, Kris Gaster, David Starks, Luis Rojas Espaillat, Pradip De, Nandini Dey
Atlas of Tumor and Tumor Microenvironment Cells of Lymphovascular Space Invasion (LVSI) in High-Grade Serous Endometrial Adenocarcinoma: A Case Study. International journal of molecular sciences 25 (6) (2024)
Raed Sulaiman, Pradip De, Jennifer Carlson Aske, Xiaoqian Lin, Adam Dale, Nischal Koirala, Kris Gaster, Luis Rojas Espaillat, David Starks, Nandini Dey
Patient-Derived Primary Cancer-Associated Fibroblasts Mediate Resistance to Anti-Angiogenic Drug in Ovarian Cancers. Biomedicines 11 (1) (2023)
Raed Sulaiman, Pradip De, Jennifer Carlson Aske, Xiaoqian Lin, Adam Dale, Nischal Koirala, Kris Gaster, Luis Rojas Espaillat, David Starks, Nandini Dey
Tumor-TME Bipartite Landscape of PD-1/PD-L1 in Endometrial Cancers. International journal of molecular sciences 24 (13) (2023)
Raed Sulaiman, Pradip De, Jennifer Carlson Aske, Xiaoqian Lin, Adam Dale, Kris Gaster, Luis Rojas Espaillat, David Starks, Nandini Dey
Characterization and Clinical Relevance of Endometrial CAFs: Correlation between Post-Surgery Event and Resistance to Drugs. International journal of molecular sciences 24 (7) (2023)
Raed Sulaiman, Pradip De, Jennifer Carlson Aske, Xiaoqian Lin, Adam Dale, Kris Gaster, Luis Rojas Espaillat, David Starks, Nandini Dey
A CAF-Based Two-Cell Hybrid Co-Culture Model to Test Drug Resistance in Endometrial Cancers. Biomedicines 11 (5) (2023)
Raed Sulaiman, Pradip De, Jennifer Carlson Aske, Xiaoqian Lin, Adam Dale, Nischal Koirala, Kris Gaster, Luis Rojas Espaillat, David Starks, Nandini Dey
Patient-Derived Primary Cancer-Associated Fibroblasts Mediate Resistance to Anti-Angiogenic Drug in Ovarian Cancers. Biomedicines 11 (1) (2023)
Raed Sulaiman, Pradip De, Jennifer Carlson Aske, Xiaoqian Lin, Adam Dale, Ethan Vaselaar, Nischal Koirala, Cheryl Ageton, Kris Gaster, Joshua Plorde, Benjamin Solomon, Bradley Thaemert, Paul Meyer, Luis Rojas Espaillat, David Starks, Nandini Dey
A Laboratory-Friendly CTC Identification: Comparable Double-Immunocytochemistry with Triple-Immunofluorescence. Cancers 14 (12) (2022)
Raed Sulaiman, Pradip De, Jennifer Carlson Aske, Xiaoqian Lin, Adam Dale, Ethan Vaselaar, Cheryl Ageton, Kris Gaster, Luis Rojas Espaillat, David Starks, Nandini Dey
Identification and Morphological Characterization of Features of Circulating Cancer-Associated Macrophage-like Cells (CAMLs) in Endometrial Cancers. Cancers 14 (19) (2022)
Pradip De, Jennifer Carlson Aske, Raed Sulaiman, Nandini Dey
Bête Noire of Chemotherapy and Targeted Therapy: CAF-Mediated Resistance. Cancers 14 (6) (2022)
Nischal Koirala, Nandini Dey, Jennifer Carlson Aske, Pradip De
Targeting Cell Cycle Progression in HER2+ Breast Cancer: An Emerging Treatment Opportunity. International journal of molecular sciences 23 (12) (2022)
Nandini Dey, Jennifer Carlson Aske, Pradip De
Targeted Neoadjuvant Therapies in HR+/HER2-Breast Cancers: Challenges for Improving pCR. Cancers 13 (3) (2021)
Dey Nandini, Jennifer Carlson Aske, De Pradip
Therapeutic Strategies for Metastatic Triple-Negative Breast Cancers: From Negative to Positive. Pharmaceuticals (Basel, Switzerland) 14 (5) (2021)
De Pradip, Jennifer Carlson Aske, Dey Nandini
Cancer-Associated Fibroblasts in Conversation with Tumor Cells in Endometrial Cancers: A Partner in Crime. International journal of molecular sciences 22 (17) (2021)
Pradip De, Jennifer Carlson Aske, Nandini Dey
Cancer-Associated Fibroblast Functions as a Road-Block in Cancer Therapy. Cancers 13 (20) (2021)
Pradip De, Brett James Rozeboom, Jennifer Carlson Aske, Nandini Dey
Active RAC1 Promotes Tumorigenic Phenotypes and Therapy Resistance in Solid Tumors. Cancers 12 (6) (2020)
Pradip De, Jennifer Carlson Aske, Nandini Dey
RAC1 Takes the Lead in Solid Tumors. Cells 8 (5) (2019)

Jennifer Carlson Aske.css-eqlu8i{font-size:small;padding-left:4px;} (Aske Jennifer, Jennifer Aske, Jennifer C Aske)

Publication Activity (10 Years)

Top Topics

Top Venues

Jennifer Carlson Aske (Aske Jennifer, Jennifer Aske, Jennifer C Aske)